Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Richard Pazdur

FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2019English

U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2016English

FDA Approval: Blinatumomab for Patients With B-Cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission With Minimal Residual Disease

Clinical Cancer Research
Cancer ResearchOncology
2019English

An FDA Perspective on the Regulatory Implications of Complex Signatures to Predict Response to Targeted Therapies

Clinical Cancer Research
Cancer ResearchOncology
2016English

FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

Nonclinical Evaluations of Small-Molecule Oncology Drugs: Integration Into Clinical Dose Optimization and Toxicity Management

Clinical Cancer Research
Cancer ResearchOncology
2016English

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia With an Isocitrate Dehydrogenase-1 Mutation

Clinical Cancer Research
Cancer ResearchOncology
2019English

Real‐world Progression, Treatment, and Survival Outcomes During Rapid Adoption of Immunotherapy for Advanced Non–small Cell Lung Cancer

Cancer
Cancer ResearchOncology
2019English

Regulatory Considerations on Endpoints in Ovarian Cancer Drug Development

Cancer
Cancer ResearchOncology
2017English

Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies

Oncologist
Cancer ResearchMedicineOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy